Pharma

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

By

This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.

5 of healthcare's hardest nuts to crack

5 of healthcare's hardest nuts to crack

How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?

Is a Crisis Brewing for Watson Health?

Is a Crisis Brewing for Watson Health?

By

In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.

Five things for pharma marketers to know: Wednesday, April 5, 2017

Five things for pharma marketers to know: Wednesday, April 5, 2017

By

GSK pulls ads from "The O'Reilly Factor"; the FDA approves drug for Huntington's disease patients; lawmakers may remove pre-existing conditions requirement

Top 40 Healthcare Transformers of 2017

Top 40 Healthcare Transformers of 2017

Each year MM&M honors 40 upstarts and veteran innovation gurus who are leading the transformation of the biopharma industry.

Melinda Richter, Johnson & Johnson

Melinda Richter, Johnson & Johnson

Melinda Richter is head of JLABS at Johnson & Johnson.

David Van Sickle, Propeller Health

David Van Sickle, Propeller Health

David Van Sickle is CEO and co-founder of Propeller Health.

Jenny Streets, AstraZeneca

Jenny Streets, AstraZeneca

Jenny Streets is the senior director of customer experience and innovation at AstraZeneca.

Lisa Flaiz, formerly of Janssen

Lisa Flaiz, formerly of Janssen

Lisa Flaiz is the former group product director of digital marketing at Janssen.

Bruno Villetelle, Takeda Pharmaceutical

Bruno Villetelle, Takeda Pharmaceutical

Bruno Villetelle is chief digital officer at Takeda Pharmaceutical.

Behshad Sheldon, Braeburn Pharmaceuticals

Behshad Sheldon, Braeburn Pharmaceuticals

Behshad Sheldon is president and CEO and Braeburn Pharmaceuticals.

Kristin Milburn, Novartis

Kristin Milburn, Novartis

Kristin Milburnis head of strategic partnerships and the digital acceleration lab at Novartis.

Matias Coo, Avanir

Matias Coo, Avanir

Matias Coo is director of digital marketing for Avanir.

Top 10 Innovation Catalysts of 2017

Top 10 Innovation Catalysts of 2017

For the first time MM&M is honoring a group of 10 agency executives working to assist emerging start-ups in order to bring disruptive innovation back to their clients.

What five different pharma marketing careers look like

What five different pharma marketing careers look like

Five highly placed insiders in a range of roles and therapeutic categories share secrets to their success and advice that served them well along the way.

Five things for pharma marketers to know: Friday, March 24, 2017

Five things for pharma marketers to know: Friday, March 24, 2017

By

Lilly to invest $850 million in the U.S.; President Trump gives GOP leaders ultimatum on healthcare bill; Pfizer, Merck KGaA receive FDA approval for Bavencio

Five things for pharma marketers to know: Wednesday, March 22, 2017

Five things for pharma marketers to know: Wednesday, March 22, 2017

By

Novartis' heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron's Xadago for PD

 MM&M Startup Showdown connects startups with biopharma execs

MM&M Startup Showdown connects startups with biopharma execs

By

This program is designed to enable entrepreneurs and biopharma marketers to engage in an intelligent way to explore beyond-the-pill partnerships.

Saturday at SXSW: Hooray for health

Saturday at SXSW: Hooray for health

By

The first days at SXSW Health went deep on entrepreneurship and the marketing thereof.

MM&M conference to explore beyond-the-pill

MM&M conference to explore beyond-the-pill

By

The MM&M Transforming Healthcare Conference will be held May 1 in New York City.

Havas combines Havas Health, Havas consumer health practices into new entity

Havas combines Havas Health, Havas consumer health practices into new entity

By

The organization is now called Havas Health & You and continues to be led by Donna Murphy.

Five things for pharma marketers to know: Monday, March 6, 2017

Five things for pharma marketers to know: Monday, March 6, 2017

By

Gilead exec blames PBMs for high drug prices; Google uses AI to detect signs of breast cancer; Sanofi and Regeneron drug effective in treating eczema

Five things for pharma marketers to know: Thursday, March 2, 2017

Five things for pharma marketers to know: Thursday, March 2, 2017

By

Ten drugmakers seek to exclude pricing information from proxy ballots; roughly 85% of patient advocacy groups get industry funding; Juno halts lead CAR-T project

Another Pharmageddon? The Looming Threat to 2017 Ad Budgets

Another Pharmageddon? The Looming Threat to 2017 Ad Budgets

By

Despite budgets bouncing back from a decrease in 2015, big threats have appeared that may temper future plans, Iskowitz writes.

MM&M's top 5 stories in February 2017

MM&M's top 5 stories in February 2017

By

WPP creates WPP Health & Wellness; Publicis Health formalizes new name; 10 ways healthcare companies are testing Instagram

Five things for pharma marketers to know: Tuesday, February 28, 2017

Five things for pharma marketers to know: Tuesday, February 28, 2017

By

J&J discloses list prices for its drugs; Kite's CAR-T therapy meets study goals; healthcare providers seek to engage patients in decisionmaking

What uncertainty? 72% of health marketers say 2017 budgets are up

What uncertainty? 72% of health marketers say 2017 budgets are up

By

This according to the 172 healthcare marketing executives who participated in the 2017 MM&M/Guidemark Health Healthcare Marketers Trend Report.

Guidemark Health's Sophy Regelous on why small budgets are increasing

Guidemark Health's Sophy Regelous on why small budgets are increasing

By

Guidemark Health COO Sophy Regelous shares her perspective on the 2017 MM&M/Guidemark Health Healthcare Marketers Report.

Is the Trump Administration the Cure the FDA Needs?

Is the Trump Administration the Cure the FDA Needs?

Finally, a Congress and president who see pharma as a resource and not a villain, Flaum writes.

MAHF honors Abbate and Lazur, Future Famers

MAHF honors Abbate and Lazur, Future Famers

By

The Medical Advertising Hall of Fame recognized dozens of industry leaders and rising agency executives.

OPINION

Newsletters